Home   >   CSC-OpenAccess Library   >    Manuscript Information
Full Text Available

This is an Open Access publication published under CSC-OpenAccess Policy.
Publications from CSC-OpenAccess Library are being accessed from over 158 countries worldwide.
Drug Target Identification Using Gene Expression Microarray Data of Toxoplasma Gondii
Budhayash Gautam, Pramod Katara, Satendra Singh, Rohit Farmer
Pages - 113 - 124     |    Revised - 30-06-2010     |    Published - 10-08-2010
Volume - 4   Issue - 3    |    Publication Date - July 2010  Table of Contents
Toxoplasma gondii, Toxoplasmosis, Microarray data analysis, Co-expression
Toxoplasma gondii is an obligate intracellular Apicomplexan parasite that can infect a wide range of warmblooded animals including humans. This pathogen is one of the most common in humans due to many contributing factors that include: (1) its complex life cycle allows it to be transmitted both sexually via felid fecal matter and asexually via carnivorism. (2) Toxoplasma has an extremely wide host cell tropism that includes most nucleated cells. (3) In humans and other intermediate hosts, Toxoplasma develops into a chronic infection that cannot be eliminated by the host’s immune response or by currently used drugs. In most cases, chronic infections are largely asymptomatic unless the host becomes immune compromised and often suffer from life threatening encephalitis. Unfortunately, owing to the toxic side effects and general low efficacy of all known drugs for toxoplasmosis, new chemotherapeutic agents are urgently required. The mechanisms by which Toxoplasma grows within its host cell, encysts, and interacts with the host’s immune system are important questions. The use of DNA microarrays in transcriptional profiling, genotyping, and epigenetic experiments has impacted our understanding of these processes. In the past years, many existing data analysis methods from other fields have been applied to gene expression data. Among these, clustering methods are a large family of commonly used data analysis methods. Clustering methods are particularly useful in the analysis of gene expression data and organization of gene expression data. In present work Hierarchical and kmeans clustering methods have been used for the analysis of microarray gene expression data of Toxoplasma gondii with the help of Genesis tool. On the basis of coexpression, some probable gene targets in Toxoplasma gondii have been found (IL-16 and Inhibitor of kappa light chain Epsilon etc.). Their promoters have been predicted with Neural Network Promoter Predictor, of BDGP. Predicted promoters were aligned using ClustalW to SAG family members, (which are related to the invasion or surface attachment of the parasite to the host cell) to see common regulation. They showed good amount of sequence similarity with the already known targeted genes of SAG family. These probable targets have important functions in the case of encephalitis in AIDS patient caused by Toxoplasma gondii, as these targets play major role in prevention of AIDS.
CITED BY (3)  
1 Webb, A. R., & Copsey, k. d. ttern statistical.
2 Gautam, B., Singh, G., Singh, A. K., & Wadhwa, G. (2013). Analyzing time course microarray data of Toxoplasma gondii and study the impact on host transcript levels using Bioconductor. Indian Journal of Biotechnology, 12(1), 46-51.
3 Gautam, B., Singh, G., & Singh, S. (2012). Analyzing time course microarray data of Toxoplasma gondii asexual development and identification of developmentally regulated genes using bioconductor.
1 Google Scholar 
2 Academic Journals Database 
3 Academic Index 
4 CiteSeerX 
5 refSeek 
6 Socol@r  
7 Libsearch 
8 Bielefeld Academic Search Engine (BASE) 
9 Scribd 
10 WorldCat 
11 SlideShare 
13 PdfSR 
1 U. Singh, J. L. Brewer and J. C. Boothroyd. “Genetic analysis of tachyzoite to bradyzoite differentiation mutants in Toxoplasma gondii reveals a hierarchy of gene induction”. Molecular Microbiology.44(3):721–33, (2002).
2 M. S. Behnke. “The transcription of bradyzoite genes in Toxoplasma gondii is controlled by autonomous promoter elements”. Molecular Microbiology.68(6):1502–18, (2008).
3 J. P. Dubey, D. S. Lindsay and C.A.Speer. “Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts”.Clinical Microbiology Review, 11, 267-299,(1998).
4 A. P. Sinai and K. A.Joiner. “Safe haven: the cell biology of nonfusogenic pathogen vacuoles”. Annual Review of Microbiology.51:415–62, (1997).
5 I. Coppens. “Toxoplasma gondii sequesters lysosomes from mammalian hosts in the vacuolar space”. Cell. 125(2):261–74 (2006).
6 M. E. Walker. “Toxoplasma gondii actively remodels the microtubule network in host cells”. Microbes and Infection. 10(14–15):1440–9, (2008).
7 S. K. Halonen and E. Weidner. “Overcoating of Toxoplasma parasitophorous vacuoles with host cell vimentin type intermediate filaments”. Journal of Eukaryotic Microbiology. 41(1):65–71 (1994).
8 P. B. Nash. “Toxoplasma gondii-infected cells are resistant to multiple inducers of apoptosis”. Journal of Immunology. 160(4):1824–30, (1998).
9 S. Goebel, C. G. Luder and U. Gross. “Invasion by Toxoplasma gondii protects human-derived HL-60 cells from actinomycin Dinduced apoptosis”. Medical Microbiology and Immunology. 187(4):221–6, (1999).
10 Z. Y. Li. “Toxoplasma gondii soluble antigen induces a subset of lipopolysaccharide-inducible genes and tyrosine phosphoproteins in peritoneal macrophages”. Infection and Immunity 62(8):3434–40, (1994).
11 M. P. Brenier-Pinchart. “Toxoplasma gondii induces the secretion of monocyte chemotactic protein-1 in human fibroblasts, in vitro”. Molecular and Cellular Biochemistry, 209(1–2):79–87, (2000).
12 S. Yap and A. Sher “Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function”. Immunobiology. 201(2):240–7,(1999).
13 C. F. Denney, L. Eckmann. and S. L. Reed. “Chemokine secretion of human cells in response to Toxoplasma gondii infection”. Infection and Immunity 67(4):1547–52, (1999).
14 J. D. Schwartzman and E. R. Pfefferkorn. “Toxoplasma gondii: purine synthesis and salvage in mutant host cells and parasites”. Experimental Parasitology. 53(1):77–86, (1982).
15 I. Coppens, A. P. Sinai. and K. A. Joiner. “Toxoplasma gondii exploits host low-density lipoprotein receptor-mediated endocytosis for cholesterol acquisition”. Journal Cell Biology. 149(1):167–80 (2000).
16 M. Gail, U. Gross and W. Bohne. “Transcriptional profile of Toxoplasma gondii-infected human fibroblasts as revealed by gene-array hybridization”. Molecular Genetics and Genomics. 265(5):905–12, (2001).
17 I. J. Blader, I. D. Manger and J. C. Boothroyd. “Microarray analysis reveals previously unknown changes in Toxoplasma gondii-infected human cells”. Journal of Biological Chemistry. 276(26):24223–31 (2001).
18 D. Chaussabel. “Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites”. Blood. 102(2):672–81, (2003).
19 J. C. Boothroyd. “DNA microarrays in parasitology: strengths and limitations”. Trends in Parasitology. 19(10):470–6, (2003).
20 I. D. Manger. “Expressed sequence tag analysis of the bradyzoite stage of Toxoplasma gondii: identification of developmentally regulated genes”. Infections and Immunity. 66(4):1632–7, (1998).
21 M. D. Cleary. “Toxoplasma gondii asexual development: identification of developmentally regulated genes and distinct patterns of gene expression”. Eukaryotic Cell. 1(3):329–40, (2002). [20] M. Matrajt. “Identification and characterization of differentiation mutants in the protozoan parasite Toxoplasma gondii”. Molecular Microbiology.44(3):735–47, (2002).
22 U. Singh, J. L. Brewer and J. C. Boothroyd. “Genetic analysis of tachyzoite to bradyzoite differentiation mutants in Toxoplasma gondii reveals a hierarchy of gene induction”. Molecular Microbiology.44(3):721–33, (2002).
23 B. Dannemann. “Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group”. Annals of Internal Medicine. 16(1):33–43, (1992).
24 H. Baatz. “Reactivation of toxoplasma retinochoroiditis under atovaquone therapy in an immunocompetent patient”. Ocular Immunology & Inflammation. 14(3):185–7, (2006).
25 T. V. Aspinall. “The molecular basis of sulfonamide resistance in Toxoplasma gondii and implications for the clinical management of toxoplasmosis”. Journal of Infectious Disease. 185(11):1637–43, (2002).
26 M. D. Brazas and R. E. Hancock. “Using microarray gene signatures to elucidate mechanisms of antibiotic action and resistance”. Drug Discovery Today. 10(18):1245–52, (2005).
27 B. Luft. and J. S. Remington. “AIDS commentary: toxoplasmic encephalitis in AIDS”. Clinical Infectious Diseases. 15:211–222. (1992).
28 D. E. Jr Bassett, M. B. Eisen and M. S. Boguski. “Gene expression informatics--it's all in your mine”. Nature Genetics. Jan;21(1 Suppl):51-5, (1999).
29 Debouck, C. and Goodfellow, P. N. (1999). DNA microarrays in drug discovery and development. Nat Genet. 21(1): 48–50 [PMID: 9915501]
30 A. Brazma, A. Robinson, G. Cameron and M. Ashburner. “One-stop shop for microarray data”. Nature. Feb 17;403(6771):699-700, (2000).
31 A. Brazma and J. Vilo. ”Gene expression data analysis”. FEBS Letters, Aug 25; 480(1):17-24 (2000).
32 M. B. Eisen, P. T. Spellman, P. O. Brown and D. Botstein. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A. 8;95(25):14863-8.[PMID: 9843981]
33 Heyer, L. J., Kruglyak, S. and Yooseph, S. (1999). “Exploring expression data: identification and analysis of coexpressed genes”. Genome Research. Nov;9(11):1106-15, (1998).
34 http://genome-www5.stanford.edu/
35 http://genome-www5.stanford.edu/
36 A. Sturn, J. Quackenbush, and Z. Trajanoski. “Genesis: cluster analysis of microarray data”. Bioinformatics. 18: 207-208. (2002).
37 A. H. Waibel et al. “IEEE Transactions on Acoustic, Speech, and Signal Processing”. 37(3):328-339, (1989).
38 http://www.ebi.ac.uk/Tools/clustalw2/index.html.
39 V., D. Nakaar, K. R. Bermudes and K. A. Joiner. “Upstream elements required for expression of nucleoside triphosphate hydrolase genes of Toxoplasma gondii”. Molecular and Biochemical Parasitology. 92:229–239, (1998).
40 D. J. Ferguson and W. M. Hutchison. “An ultrastructural study of the early development and tissue cyst formation of Toxoplasma gondii in the brains of mice.” Parasitology Research. 73:483–491 (1987).
41 ] S. Chu, J. DeRisi, M. Eisen, J. Mulholland, D. Botstein, P. O. Brown and I. Herskowitz. “The transcriptional program of sporulation in budding yeast”. Science 282:699–705, (1998).
42 P. J. Gaddi and G. S. Yap. “Cytokine regulation of immunopathology in toxoplasmosis”. Immunology & Cell Biology. 85(2):155–9, (2007).
43 I. J. Blader and J. P. Saeij. “Communication between Toxoplasma gondii and its host: impact on parasite growth, development, immune evasion, and virulence”. APMIS. 117(5–6):458–76 (2009).
44 S. K. Kim, A. E. Fouts and J. C. Boothroyd. “Toxoplasma gondii dysregulates IFN-gamma-inducible gene expression in human fibroblasts: insights from a genome-wide transcriptional profiling”. Journal of Immunology. 178(8):5154–65. (2007).
45 C. G. Luder. “Toxoplasma gondii down-regulates MHC class II gene expression andantigen presentation by murine macrophages via interference with nuclear translocation of STAT1alpha”. European Journal of Immunology. 31(5):1475–84, (2001).
46 K. M. Brown and J. Blader. “The role of DNA microarrays in Toxoplasma gondii reserch the causative agent of ocular toxoplasmosis”. Journal of Ocular biology disease & Informatics; 2:214-222, (2009).
Mr. Budhayash Gautam
SHIATS, Allahabad - India
Mr. Pramod Katara
Banasthali University, - India
Mr. Satendra Singh
- India
Mr. Rohit Farmer
- India